Summary
Forty-one diabetic patients with symptomatic diabetic neuropathy were studied together with an equal number of matched diabetic subjects without neuropathy. The acetylator status was determined and HLA-A, B, C and DR antigens were investigated. Metabolic control was assessed by measurement of glycosylated haemoglobin and by the mean of multiple random clinic blood glucose values. No significant difference was observed between the two groups in the proportion of fast and slow acetylators. The distribution of HLA frequencies was similar in subjects with and without neuropathy for both Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients. When compared with diabetic subjects without neuropathy, the neuropathy group had higher levels of both glycosylated haemoglobin (mean ± SEM: 50.1±1.4 versus 57.5±1.8 mmol hydroxymethylfurfural/mol haemoglobin (10.5±0.3 versus 12.0±0.4% haemoglobin A1, p < 0.01) and mean blood glucose (9.3±0.4 versus 11.3±0.5 mmol/l, p < 0.005). This study provides no evidence that genetic factors increase the susceptibility of diabetic patients to develop neuropathy. In contrast, the elevated glycosylated haemoglobin and blood glucose levels strengthen the association between hyperglycaemia and diabetic neuropathy.
Article PDF
Similar content being viewed by others
References
Ellenberg M (1982) Diabetic neuropathy. Compr Ther 8: 21–31
Clements RS (1979) Diabetic neuropathy: new concepts of its aetiology. Diabetes 28: 604–611
Thomas PK, Ward JD, Watkins PJ (1982) Diabetic neuropathy. In: Keen H, Jarrett J (eds) Complications of diabetes, 2nd edn. Edward Arnold, London, pp 109–136
Greene DA, de Jesus PV, Winegrad AI (1975) Effects of insulin and dietary myoinositol on impaired peripheral motor conduction velocity in acute streptozotocin rats J Clin Invest 55: 1326–1336
Pirart J (1965) Diabetic neuropathy: a metabolic or a vascular disease. Diabetes 14: 1–9
Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients between 1947–1973. Diabetes Care 1: 168–188 and 252–263
Ellenberg M (1958) Diabetic neuropathy precipitating after institution of diabetic control. Am J Med Sci 236: 466–471
Ellenberg M (1959) Diabetic neuropathy precipitated by diabetic control with tolbutamide. JAMA 169: 1755–1757
Pietri A, Ehle AL, Raskin P (1980) Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes 29: 668–671
Porte D, Graf RJ, Halter JB, Pfeifer MA, Halar E (1981) Diabetic neuropathy and plasma glucose control. Am J Med 70: 195–200
Pyke DA, Tattersall RB (1973) Diabetic retinopathy in identical twins. Diabetes 22: 613–618
Lunde PM, Frislid K, Hansteen V (1977) Disease and acetylator polymorphism. Clin Pharmacokinet 2: 182–197
McLaren EH, Burden AC, Moorhead PJ (1977) Acetylator phenotype in diabetic neuropathy. Br Med J 2: 291–293
Bodansky HJ, Drury PL, Cudworth AG, Price Evans DA (1981) Acetylator phenotypes and Type 1 (insulin-dependent) diabetics and microvascular disease. Diabetes 30: 907–910
Shenfield GM, McCann VJ, Tjokresetio R (1982) Acetylator status and diabetic neuropathy. Diabetologia 22: 441–444
Bodansky HJ, Wolf E, Cudworth AG, Dean BM, Nineham LJ, Botazzo GF, Matthews JA, Kurtz AB, Kohner EM (1982) Genetic and immunological factors in microvascular disease in Type 1 (insulin-dependent) diabetes. Diabetes 31: 70–74
Dornan TL, Ting A, McPherson CK, Peckar CO, Mann JI, Turner RC, Morris PJ (1982) Genetic susceptibility to the development of retinopathy in insulin-dependent diabetes. Diabetes 31: 226–231
Cudworth AG, Bodansky HJ (1982) Genetic and metabolic factors in relation to the prevalence and severity of diabetic complications. In: Keen H, Jarrett RJ (eds) Complications of diabetes, 2nd Edn. Edward Arnold, London, pp 1–12
Yao JST, Hobbs JT, Irvine WT (1969) Ankle systolic pressure measurement in arterial disease affecting the lower extremities. Br J Surg 56: 676–679
Boulton AJM, Hardisty CA, Betts RP, Franks CI, Worth RC, Ward JD, Duckworth T (1983) Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 6: 26–33
Festenstein H, Adams E, Burke Y, Oliver RTD, Sachs JA, Wolf E (1972) The distribution of HLA antigens in ex-patriates from East Bengal living in London. In: Dausset J, Colombani J (eds) Histocompatibility testing. Munksgaard, Copenhagen, pp 175–178
Van Rood JJ, Van Loewen A, Ploem JS (1976) Simultaneous detection of two cell population by two colour fluorescence and application to the recognition of B-cell determinants. Nature 262: 795–797
Evans DAP (1969) An improved and simplified method of detecting the acetylator phenotype. J Med Genet 6: 405–407
Fluckiger R, Winterhalter KM (1976) In vitro synthesis of haemoglobin A1C. FEBS Lett 71: 356–360
Fluckiger R, Harmon W, Meier W, Loo S, Gabbay KH (1981) Hemoglobin carbamylation in uremia. N Engl J Med 304: 823–827
Cudworth AG, Wolf E (1982) The genetic susceptibility to Type 1 (insulin-dependent) diabetes mellitus. In: Johnston DG, Alberti KGMM (eds) New aspects of diabetes. Clin endocrinol metab 11: 389–408
Barbosa JJ, Noreen H, Goetz F, Simmons R, de Leiva A, Najarian J, Yunis E (1976) Histocompatibility (HLA) antigens and diabetic microangiopathy. Tissue Antigens 7: 233–237
Barbosa JJ, Ramsey RC, Knobloch WC, Cantrill HL, Noreen H, King R, Yunis E (1980) Histocompatibility antigen frequencies in diabetic retinopathy. Am J Ophthamol 90: 148–153
Prikhozhan VM (1977) Aetiology and pathogenesis of diabetic neuropathy. In: Prikhozhan VM (ed) Affection of the nervous system in diabetes mellitus. Mir Publishers, Moscow, pp 191–242
Boulton AJM, Drury J, Clarke BF, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–390
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boulton, A.J.M., Worth, R.C., Drury, J. et al. Genetic and metabolic studies in diabetic neuropathy. Diabetologia 26, 15–19 (1984). https://doi.org/10.1007/BF00252256
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00252256